Sobre la Empresa
- Nombre legal: Chengdu Yacht Bio-technology Co., Ltd
- País de registro: China
- Dirección: No.7 Mansion, Tianfu Life Science Park, South Keyu, Chengdu • Sichuan
- Número de empleados: 100 - 249
- Año de fundación: 2004
Descripción:
Chengdu Yacht Bio-technology is engaged in the R&D, production and sales of APIs, biological drugs and intermediates across therapeutic fields including anti-tumor, anti-infective and immune system treatments. Its subsidiary, Sichuan Novals Pharmaceuticals, upholds a quality-and-service-first principle to provide high-quality products and solutions, with main products including daptomycin, micafungin, caspofungin, everolimus, dalbavancin and anidulafungin.
Actividades Comerciales
Ingredientes Biológicos y de Fermentación
Fabricante
Ingredientes Farmacéuticos Activos (API)
Fabricante de Principios Activos (API)
IFA de Marca Original
Fabricante de Principios Activos (API)
Mercados de Venta
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- Northern Europe: Denmark, Estonia, Finland, Ireland, Latvia, Lithuania, Sweden
- Southern Europe: Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain
- Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia
- Western Europe: Austria, Belgium, France, Germany
Productos/Servicios Clave
- Ingredientes Farmacéuticos Activos (API): Dalbavancin, Bio-synthesis and semi-synthesis APIs
- Formas Farmacéuticas Terminadas: Finished dosage forms
- Químicos Farmacéuticos: Caspofungin Acetate, Micafungin sodium, DALBAVANCIN HYDROCHLORIDE
- IFA de Marca Original: Caspofungin Acetate, Everolimus, Micafungin sodium, Dalbavancin
Nuestros Productos & Servicios
Certifications
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Calificaciones
(0)
(0)
(0)
(0)
(0)
Comentarios
Filtros:
Ordenar por:
No hay comentarios disponibles.
Deja tu valoración & comentario